Latest technology news and innovations
Explore the implications of rising Chinese biotech development and the potential impact of FDA nominee Heidi Overton on U.S. drug regulation.
An Indonesian court's decision against patent evergreening signals a shift towards improved medicine access, resonating with patient advocates globally.
Kyverna's recent study shows promising, enduring autoimmune relief from its cell therapy, signaling a significant advancement in treatment options.
Heidi Overton's Senate hearing as FDA commissioner nominee underscores urgency in drug approvals, while states weigh Medicaid pricing choices.
Insurers are opposing Medicare's new proposal that alters how remote patient monitoring services are delivered, raising concerns over patient care management.
Gilead Sciences is ramping up its commitment to inflammation and immunology, crucial for its future growth alongside virology and oncology.
Heidi Overton's ascent from a small New Mexico town to FDA commissioner nominee reflects her commitment to public health and leadership.
Radiology is evolving as practices actively adopt AI technologies to enhance services and attract talent, moving beyond fears of obsolescence.
Eli Lilly's latest breast cancer therapy has gained FDA approval, paving the way for enhanced treatment options in oncology.
Novo Nordisk outlines its strategy to broaden its pipeline, while Alkermes reveals hopeful ADHD treatment data, indicating potential new markets.
Novo Nordisk aims to broaden its product pipeline beyond diabetes, targeting revenue growth with a focus on consumer-friendly approaches by 2030.
Pregnant and lactating individuals face barriers in finding relevant clinical trials due to a lack of structured data on their eligibility on ClinicalTrials.gov.
The FDA's approval of daraxonrasib provides new hope for pancreatic cancer patients, targeting the challenging KRAS mutation and improving survival rates significantly.
Zach Lahn, GOP candidate for Iowa governor, is leveraging RFK Jr.'s support amidst a challenging race against a Democratic opponent.
This article reflects on personal health struggles and the frustrations with today's medical system, highlighting a broader skepticism towards modern treatments.
President Trump's recent announcement highlights efforts to reduce Medicaid drug prices, but many details remain unclear.
HCA Healthcare's Texas hospitals are suing Independence Blue Cross for $345,000 in claims, underlining persistent issues around prior authorization policies.
Recognizing the alcohol flush reaction is vital for East Asian communities; medical professionals play a key role in patient education about its risks.
Robert F. Kennedy Jr. introduces a new initiative to expedite autism diagnoses while addressing challenges in current methodologies.
Kennedy reinforced his anti-vaccine advocacy during a pivotal speech at a Children’s Health Defense conference, highlighting its significance ahead of upcoming elections.